Tech Company Financing Transactions
Teitur Trophics Funding Round
On 3/14/2023, Teitur Trophics raised $29.7 million in Series A funding from Sound Bioventures, Sunstone Life Science Ventures and Industrifonden.
Transaction Overview
Company Name
Announced On
3/14/2023
Transaction Type
Venture Equity
Amount
$29,692,000
Round
Series A
Investors
Sound Bioventures (Lead Investor)
Sunstone Life Science Ventures (Lead Investor)
Proceeds Purpose
The proceeds will enable Teitur to progress its lead drug candidate, TT-P34, from candidate selection into clinical development, including a Phase 1b clinical study in neurodegenerative diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Høegh-Guldbergsgade 10
Aarhus, 8000
DK
Aarhus, 8000
DK
Phone
Undisclosed
Website
Email Address
Overview
Teitur develops novel therapeutics for treating or preventing neurodegenerative diseases. Teitur is Old Norse for happiness. Our ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life. From the Sortilins family of receptors, Teitur has developed cyclic peptides with a unique potential for addressing key pathologies across several neurodegenerative disorders including Huntington's Disease, Parkinson's Disease and Frontotemporal Dementia. These diseases impact memory, behaviour, movement and mood of millions of people around the globe and Teitur strive to improve the lives of these patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simon Molgaard
Chief Scientific Officer
Anders Dalby
Co-Founder
Simon Glerup
Co-Founder
Mathias Ollendorff
Browse more venture capital transactions:
Prev: 3/14/2023: CollectiveCrunch venture capital transaction
Next: 3/14/2023: Mayan venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records on this site come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs